have or have had lymphoma or any other type of cancer.It is not known if CIMZIA is safe and effective in children.īefore receiving CIMZIA, tell your healthcare provider about all of your medical conditions, including if you: Treat moderate to severe plaque psoriasis (PsO) in adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).Treat active non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation.Treat active ankylosing spondylitis (AS).Treat moderately to severely active rheumatoid arthritis (RA).Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who have not been helped enough by usual treatments.
CIMZIA COPAY CARD ACTIVATION SKIN
You should see your healthcare provider periodically during treatment for skin examinations, especially if you have a history of skin cancer.ĬIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to: Tell your healthcare provider if you develop any changes in the appearance of your skin, including growths on your skin, during or after treatment with CIMZIA. Some people who receive CIMZIA have developed certain types of skin cancer.Also, most of these people had been treated with both a TNF blocker and another medicine called IMURAN ® (azathioprine) or PURINETHOL ® (6-mercaptopurine, 6-MP). Most of these people were male teenagers and young adult males with Crohn's disease or ulcerative colitis. Some people who receive TNF blockers, including CIMZIA, have developed a rare type of cancer which may cause death, called hepatosplenic T-cell lymphoma.People with inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis, especially those with very active disease, may be more likely to get lymphoma.These cancers are not usually seen in this age group. Some children, teenagers, and young adults who received TNF blockers, including CIMZIA, have developed lymphoma and other certain types of rare cancers, some of which have caused death.For people who receive TNF blockers, including CIMZIA, the chances of getting certain types of cancers may increase.Stop using CIMZIA, and tell your healthcare provider right away if you have any of the symptoms of an infection listed above. use the medicine Kineret ® (anakinra), Orencia ® (abatacept), Rituxan ® (rituximab), or Tysabri ® (natalizumab).Ask your healthcare provider if you do not know if you have lived in an area where these infections are common. These infections may develop or become more severe if you receive CIMZIA. live, have lived, or traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis).Ask your healthcare provider if you are not sure. were born in, live, have lived, or traveled to certain countries where there is more risk for getting TB.have tuberculosis (TB), or have been in close contact with someone with TB.People with these conditions have a higher chance for infections. have diabetes, HIV-1 or a weak immune system.get a lot of infections or have infections that keep coming back.burning when you urinate or urinate more often than normal.
0 kommentar(er)
